In a breakthrough in the field of biochemistry, researchers from the University of Toronto have identified a new class of ribosomal peptide that is hemolytic, meaning that it is capable of breaking down red blood cells. This discovery could lead to new treatments for a variety of diseases, including cancer, and could also open up new possibilities for drug delivery. The new peptide was discovered through a process of genetic engineering, and its hemolytic properties are a result of its unique structure. This peptide could be used to target and destroy diseased cells while leaving healthy cells unharmed, making it an ideal drug delivery system.

Read Full Article Here

source: Phys.org